selegiline has been researched along with Liver Dysfunction in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bonuccelli, U; Del Dotto, P | 1 |
Anttila, M; Pelkonen, O; Rautio, A; Sotaniemi, EA | 1 |
1 review(s) available for selegiline and Liver Dysfunction
Article | Year |
---|---|
Clinical pharmacokinetics of cabergoline.
Topics: Age Factors; Antiparkinson Agents; Cabergoline; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Ergolines; Female; Food-Drug Interactions; Humans; Kidney Diseases; Levodopa; Liver Diseases; Male; Selegiline; Sex Factors | 2003 |
1 other study(ies) available for selegiline and Liver Dysfunction
Article | Year |
---|---|
Marked effect of liver and kidney function on the pharmacokinetics of selegiline.
Topics: Aged; Area Under Curve; Biotransformation; Case-Control Studies; Female; Humans; Kidney; Kidney Function Tests; Liver Diseases; Liver Function Tests; Male; Middle Aged; Monoamine Oxidase Inhibitors; Selegiline | 2005 |